Autism and Schizophrenia linked by new Gene discovery

Protocadherin α (PCDHA) as a novel susceptibility gene for autism.

http://www.ncbi.nlm.nih.gov/pubmed/23031252

Research Center for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Abstract

Background:

Synaptic dysfunction has been shown to be involved in the pathogenesis of autism. We hypothesized that the protocadherin α gene cluster (PCDHA), which is involved in synaptic specificity and in serotonergic innervation of the brain, could be a suitable candidate gene for autism.

Methods:

We examined 14 PCDHA single nucleotide polymorphisms (SNPs) for genetic association with autism in DNA samples of 3211 individuals (841 families, including 574 multiplex families) obtained from the Autism Genetic Resource Exchange.

Results:

Five SNPs (rs251379, rs1119032, rs17119271, rs155806 and rs17119346) showed significant associations with autism. The strongest association (p < 0.001) was observed for rs1119032 (z score of risk allele G = 3.415) in multiplex families; SNP associations withstand multiple testing correction in multiplex families (p = 0.041). Haplotypes involving rs1119032 showed very strong associations with autism, withstanding multiple testing corrections. In quantitative transmission disequilibrium testing of multiplex fam – ilies, the G allele of rs1119032 showed a significant association (p = 0.033) with scores on the Autism Diagnostic Interview-Revised (ADI-R)_D (early developmental abnormalities). We also found a significant difference in the distribution of ADI-R_A (social interaction) scores between the A/A, A/G and G/G genotypes of rs17119346 (p = 0.002). Limitations: Our results should be replicated in an in – dependent population and/or in samples of different racial backgrounds.

Conclusion:

Our study provides strong genetic evidence of PCDHA as a potential candidate gene for autism.

———————————–

Further Reading

Non-clustered protocadherin.

http://www.ncbi.nlm.nih.gov/pubmed/21173574

Analysis of protocadherin alpha gene enhancer polymorphism in bipolar disorder and schizophrenia.

http://www.ncbi.nlm.nih.gov/pubmed/18508241

Analysis of protocadherin alpha gene deletion variant in bipolar disorder and schizophrenia.

http://www.ncbi.nlm.nih.gov/pubmed/18496207

Advertisements
This entry was posted in Autism, Genetics, Schizophrenia. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s